Publications by authors named "Katy Mercer"

Claim this Profile
A
ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trial.
Andrew Davies, Sharon Barrans, Cathy Burton, Katy Mercer, Joshua Caddy

F1000Resยท April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis